Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy
โ Scribed by JFR Robertson; AR Dixon; RI Nicholson; IO Ellis; CW Elston; RW Blamey
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 507 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Tygerberg Breast Clinic serves a heterogeneous population, and it is therefore possible to analyse prognostic factors influencing survival and to identify any possible differences between these groups. From 1978 to 1985, 568 breast cancer patients (52% white and 48% colored) were treated surgica
## BACKGROUND. Information regarding prognostic factors and survival in elderly women with metastatic breast cancer treated with tamoxifen is limited. METHODS. The data from 4 prospective clinical trials were analyzed, including information on 396 postmenopausal women with advanced breast cancer w
Background. Circulating immune complexes (CIC) have been implicated as a cause of malignancy-associated immunosuppression and disease progression. Previous attempts to remove CIC by pheresis or immunoadsorption over a Staphylococcus aureus protein A column have resulted in a few clinical responses,